Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial

The aim of this study was to evaluate the usage of mometasone furoate nasal spray in the recovery of patients with severe microsmia or anosmia induced by COVID-19. This was a prospective clinical trial on non-hospitalized adult patients with COVID-19 (>18 years) who had severe microsmia or anosmi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasiri, Hossein, Rouhani, Nima, Salehifar, Ebrahim, Ghazaeian, Monireh, Fallah, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196319/
https://www.ncbi.nlm.nih.gov/pubmed/34147912
http://dx.doi.org/10.1016/j.intimp.2021.107871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196319/
https://www.ncbi.nlm.nih.gov/pubmed/34147912
http://dx.doi.org/10.1016/j.intimp.2021.107871

Ejemplares similares